




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Geriatric Cardiology</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=2e71e407-1503-4285-96ee-581f4325ce99</link>
        <description>Clinical Topic Feed: Geriatric Cardiology</description>
        <language>en</language>

        

                <item>
                    <title>ACC Featured Jobs For October 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1790848980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>IDEAL-AF, NEXAF, PVI-SHAM-AF Provide New Evidence on Interventions That Could Improve AFib Management</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-11am-comboaf-esc-2026</link>                    <description>Three new studies presented during ESC Congress 2026 are shedding light on how best to treat and manage atrial fibrillation (AFib). From catheter ablation strategies to rhythm-control procedures and tailored exercise programs, the IDEAL-AF, NEXAF and PVI-SHAM-AF trials provide fresh evidence on interventions that could improve outcomes and quality of life.</description>
                    <pubdate>1788102900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>STAREE: Can Statin Therapy Help Prevent CV Events in Healthy, Community-Dwelling, Older Adults?</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-215am-staree-esc-2026</link>                    <description>Among community-dwelling older adults, treatment with atorvastatin demonstrated a 30% relative reduction in major cardiovascular events over roughly six years compared with placebo but did not result in longer disability-free survival, based on findings from the STAREE trial presented at ESC Congress 2026 and simultaneously published in NEJM.</description>
                    <pubdate>1787991840000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Scientific Statement Addresses Cognitive Impairment, Frailty in Patients With CV Disease</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/ACC-Scientific-Statement-Addresses-Cognitive-Impairment-Frailty</link>                    <description>With older adults rarely experiencing cardiovascular disease in isolation, ACC&#39;s newest Scientific Statement on &quot;Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease&quot; stresses the importance of considering cognitive impairment, frailty and physical disability within the context of cardiovascular decision-making.</description>
                    <pubdate>1786376640000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>If You Build It, Will They Come? Digital Health in AF Management</title>
<link>/Latest-in-Cardiology/Articles/2026/07/27/15/29/If-You-Build-It-Will-They-Come</link>                    <description>Atrial fibrillation (AF) is the most common sustained arrhythmia in the United States, with a nation-wide prevalence projected to reach 12.1 million by 2030.1 AF is a major driver of adverse clinical outcomes, including stroke, dementia, myocardial infarction, sudden cardiac death, heart failure, chronic kidney disease, and all-cause death.</description>
                    <pubdate>1785173940000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Poll Results: Brainstorm: Restarting Anticoagulation After Brain Bleed</title>
<link>/Latest-in-Cardiology/Articles/2026/06/29/15/28/Poll-Results-Brainstorm</link>                    <description>This poll included a clinical vignette of an 80-year-old man with atrial fibrillation (AF), high thromboembolic risk, and multiple cardiovascular (CV) comorbidities who presented 2 months after a spontaneous lobar intracerebral hemorrhage while receiving reduced-dose apixaban...</description>
                    <pubdate>1782913920000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>The P2Y12 Inhibitor Paradox: Potency vs. Safety After ACS in Older Adults</title>
<link>/Education-and-Meetings/Patient-Case-Quizzes/2026/06/23/16/56/The-P2Y12-Inhibitor-Paradox</link>                    <description>An 86-year-old woman presents to a referring hospital with acute left-sided chest pain. Her medical history is notable for hypertension, a 4.2 cm dilated ascending aortic aneurysm, and a remote subdural hematoma without seizure that occurred 2 years before presentation in the setting of recurrent mechanical falls.</description>
                    <pubdate>1782294900000</pubdate>
                    <category>Educational Activities</category>
                </item>
                <item>
                    <title>Poll: Brainstorm: Restarting Anticoagulation After Brain Bleed</title>
<link>/Latest-in-Cardiology/Articles/2026/06/08/10/20/Poll-Brainstorm</link>                    <description>An 80-year-old man presents for a cardiovascular follow-up after a prolonged hospitalization in the setting of an intracerebral hemorrhage. His medical history is relevant for atrial fibrillation, stage 3b chronic kidney disease, heart failure with preserved ejection fraction, hypertension, myocardial infarction 10 years ago, and type 2 diabetes mellitus.</description>
                    <pubdate>1780929600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Managing Cardiovascular Disease in Older Adults With Cognitive Impairment: Challenges and Practical Strategies</title>
<link>/Latest-in-Cardiology/Articles/2026/06/01/13/18/Managing-CVD-in-Older-Adults-With-Cognitive-Impairment</link>                    <description>Older adults with cardiovascular (CV) risk factors or established cardiovascular disease (CVD) are at increased risk of cognitive impairment (CI). This risk is observed across several conditions, including hypertension, atrial fibrillation (AF), heart failure, and coronary artery disease.</description>
                    <pubdate>1780331400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Hidden Barriers to GDMT: A Balancing Act</title>
<link>/Education-and-Meetings/Patient-Case-Quizzes/2026/03/18/11/59/Hidden-Barriers-to-GDMT</link>                    <description>A 72-year-old male veteran presents to the emergency department with progressive shortness of breath and generalized fatigue over the past 6 weeks. His medical history is notable for heart failure (HF) with reduced ejection fraction (EF) secondary to nonischemic cardiomyopathy with EF 35-40%...</description>
                    <pubdate>1774007940000</pubdate>
                    <category>Educational Activities</category>
                </item>

    </channel>
</rss>